Corpus
PascalFrancis
Racine
Corpus
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Apomorphine: A novel effect for an old compound

Identifieur interne : 000A92 ( PascalFrancis/Corpus ); précédent : 000A91; suivant : 000A93

Apomorphine: A novel effect for an old compound

Auteurs : Marco Scarselli ; Marianna Armogida ; Carla Pardini ; Serena Chiacchio ; Giovanni U. Corsini

Source :

RBID : Pascal:03-0237962

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0091-3952
A02 01      @0 ADNRA3
A03   1    @0 Adv. neurol.
A05       @2 86
A08 01  1  ENG  @1 Apomorphine: A novel effect for an old compound
A09 01  1  ENG  @1 Parkinson's disease
A11 01  1    @1 SCARSELLI (Marco)
A11 02  1    @1 ARMOGIDA (Marianna)
A11 03  1    @1 PARDINI (Carla)
A11 04  1    @1 CHIACCHIO (Serena)
A11 05  1    @1 CORSINI (Giovanni U.)
A12 01  1    @1 CALNE (Donald) @9 ed.
A12 02  1    @1 CALNE (Susan M.) @9 ed.
A14 01      @1 Department of Neuroscience, University of Pisa @2 56126 Pisa @3 ITA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut.
A15 01      @1 Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon @2 Vancouver, British Columbia @3 CAN @Z 1 aut. @Z 2 aut.
A18 01  1    @1 World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders" @3 INC @9 patr.
A18 02  1    @1 Pacific Parkinsons Research Institute @3 CAN @9 patr.
A20       @1 367-372
A21       @1 2001
A23 01      @0 ENG
A43 01      @1 INIST @2 15741 @5 354000109446770380
A44       @0 0000 @1 © 2003 INIST-CNRS. All rights reserved.
A45       @0 27 ref.
A47 01  1    @0 03-0237962
A60       @1 P @2 C
A61       @0 A
A64 01  1    @0 Advances in neurology
A66 01      @0 USA
C02 01  X    @0 002B17G
C02 02  X    @0 002B02B10
C03 01  X  FRE  @0 Apomorphine @2 NK @2 FR @5 02
C03 02  X  FRE  @0 Parkinson maladie @5 04
C03 02  X  ENG  @0 Parkinson disease @5 04
C03 02  X  SPA  @0 Parkinson enfermedad @5 04
C03 03  X  FRE  @0 Traitement @5 17
C03 03  X  ENG  @0 Treatment @5 17
C03 03  X  SPA  @0 Tratamiento @5 17
C03 04  X  FRE  @0 Chimiothérapie @5 18
C03 04  X  ENG  @0 Chemotherapy @5 18
C03 04  X  SPA  @0 Quimioterapia @5 18
C03 05  X  FRE  @0 Antiparkinsonien @5 19
C03 05  X  ENG  @0 Antiparkinson agent @5 19
C03 05  X  SPA  @0 Antiparkinsoniano @5 19
C03 06  X  FRE  @0 Homme @5 20
C03 06  X  ENG  @0 Human @5 20
C03 06  X  SPA  @0 Hombre @5 20
C03 07  X  FRE  @0 Agoniste @5 25
C03 07  X  ENG  @0 Agonist @5 25
C03 07  X  SPA  @0 Agonista @5 25
C03 08  X  FRE  @0 Récepteur dopaminergique @5 26
C03 08  X  ENG  @0 Dopamine receptor @5 26
C03 08  X  SPA  @0 Receptor dopaminérgico @5 26
C07 01  X  FRE  @0 Système nerveux pathologie @5 45
C07 01  X  ENG  @0 Nervous system diseases @5 45
C07 01  X  SPA  @0 Sistema nervioso patología @5 45
C07 02  X  FRE  @0 Système nerveux central pathologie @5 46
C07 02  X  ENG  @0 Central nervous system disease @5 46
C07 02  X  SPA  @0 Sistema nervosio central patología @5 46
C07 03  X  FRE  @0 Encéphale pathologie @5 47
C07 03  X  ENG  @0 Cerebral disorder @5 47
C07 03  X  SPA  @0 Encéfalo patología @5 47
C07 04  X  FRE  @0 Extrapyramidal syndrome @5 48
C07 04  X  ENG  @0 Extrapyramidal syndrome @5 48
C07 04  X  SPA  @0 Extrapiramidal síndrome @5 48
C07 05  X  FRE  @0 Maladie dégénérative @5 49
C07 05  X  ENG  @0 Degenerative disease @5 49
C07 05  X  SPA  @0 Enfermedad degenerativa @5 49
N21       @1 146
N82       @1 PSI
pR  
A30 01  1  ENG  @1 Parkinson's Disease. International Congress @3 Vancouver CAN @4 1999-07-25

Format Inist (serveur)

NO : PASCAL 03-0237962 INIST
ET : Apomorphine: A novel effect for an old compound
AU : SCARSELLI (Marco); ARMOGIDA (Marianna); PARDINI (Carla); CHIACCHIO (Serena); CORSINI (Giovanni U.); CALNE (Donald); CALNE (Susan M.)
AF : Department of Neuroscience, University of Pisa/56126 Pisa/Italie (1 aut., 2 aut., 3 aut., 4 aut., 5 aut.); Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon/Vancouver, British Columbia/Canada (1 aut., 2 aut.)
DT : Publication en série; Congrès; Niveau analytique
SO : Advances in neurology; ISSN 0091-3952; Coden ADNRA3; Etats-Unis; Da. 2001; Vol. 86; Pp. 367-372; Bibl. 27 ref.
LA : Anglais
CC : 002B17G; 002B02B10
FD : Apomorphine; Parkinson maladie; Traitement; Chimiothérapie; Antiparkinsonien; Homme; Agoniste; Récepteur dopaminergique
FG : Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED : Parkinson disease; Treatment; Chemotherapy; Antiparkinson agent; Human; Agonist; Dopamine receptor
EG : Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease
SD : Parkinson enfermedad; Tratamiento; Quimioterapia; Antiparkinsoniano; Hombre; Agonista; Receptor dopaminérgico
LO : INIST-15741.354000109446770380
ID : 03-0237962

Links to Exploration step

Pascal:03-0237962

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Apomorphine: A novel effect for an old compound</title>
<author>
<name sortKey="Scarselli, Marco" sort="Scarselli, Marco" uniqKey="Scarselli M" first="Marco" last="Scarselli">Marco Scarselli</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Armogida, Marianna" sort="Armogida, Marianna" uniqKey="Armogida M" first="Marianna" last="Armogida">Marianna Armogida</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pardini, Carla" sort="Pardini, Carla" uniqKey="Pardini C" first="Carla" last="Pardini">Carla Pardini</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Chiacchio, Serena" sort="Chiacchio, Serena" uniqKey="Chiacchio S" first="Serena" last="Chiacchio">Serena Chiacchio</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Corsini, Giovanni U" sort="Corsini, Giovanni U" uniqKey="Corsini G" first="Giovanni U." last="Corsini">Giovanni U. Corsini</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237962</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237962 INIST</idno>
<idno type="RBID">Pascal:03-0237962</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A92</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Apomorphine: A novel effect for an old compound</title>
<author>
<name sortKey="Scarselli, Marco" sort="Scarselli, Marco" uniqKey="Scarselli M" first="Marco" last="Scarselli">Marco Scarselli</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Armogida, Marianna" sort="Armogida, Marianna" uniqKey="Armogida M" first="Marianna" last="Armogida">Marianna Armogida</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pardini, Carla" sort="Pardini, Carla" uniqKey="Pardini C" first="Carla" last="Pardini">Carla Pardini</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Chiacchio, Serena" sort="Chiacchio, Serena" uniqKey="Chiacchio S" first="Serena" last="Chiacchio">Serena Chiacchio</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Corsini, Giovanni U" sort="Corsini, Giovanni U" uniqKey="Corsini G" first="Giovanni U." last="Corsini">Giovanni U. Corsini</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint>
<date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Agonist</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Dopamine receptor</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Apomorphine</term>
<term>Parkinson maladie</term>
<term>Traitement</term>
<term>Chimiothérapie</term>
<term>Antiparkinsonien</term>
<term>Homme</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0091-3952</s0>
</fA01>
<fA02 i1="01">
<s0>ADNRA3</s0>
</fA02>
<fA03 i2="1">
<s0>Adv. neurol.</s0>
</fA03>
<fA05>
<s2>86</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG">
<s1>Apomorphine: A novel effect for an old compound</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG">
<s1>Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1">
<s1>SCARSELLI (Marco)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>ARMOGIDA (Marianna)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>PARDINI (Carla)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>CHIACCHIO (Serena)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>CORSINI (Giovanni U.)</s1>
</fA11>
<fA12 i1="01" i2="1">
<s1>CALNE (Donald)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1">
<s1>CALNE (Susan M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01">
<s1>Department of Neuroscience, University of Pisa</s1>
<s2>56126 Pisa</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA15 i1="01">
<s1>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1">
<s1>World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders"</s1>
<s3>INC</s3>
<s9>patr.</s9>
</fA18>
<fA18 i1="02" i2="1">
<s1>Pacific Parkinsons Research Institute</s1>
<s3>CAN</s3>
<s9>patr.</s9>
</fA18>
<fA20>
<s1>367-372</s1>
</fA20>
<fA21>
<s1>2001</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>15741</s2>
<s5>354000109446770380</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>27 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>03-0237962</s0>
</fA47>
<fA60>
<s1>P</s1>
<s2>C</s2>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Advances in neurology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B02B10</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Chimiothérapie</s0>
<s5>18</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Chemotherapy</s0>
<s5>18</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Quimioterapia</s0>
<s5>18</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Antiparkinsonien</s0>
<s5>19</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Antiparkinson agent</s0>
<s5>19</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Antiparkinsoniano</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Agoniste</s0>
<s5>25</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Agonist</s0>
<s5>25</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Agonista</s0>
<s5>25</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Récepteur dopaminergique</s0>
<s5>26</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Dopamine receptor</s0>
<s5>26</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Receptor dopaminérgico</s0>
<s5>26</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>45</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>46</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>46</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>46</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>47</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>47</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>47</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>48</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>48</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>48</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>49</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>49</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>49</s5>
</fC07>
<fN21>
<s1>146</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
<pR>
<fA30 i1="01" i2="1" l="ENG">
<s1>Parkinson's Disease. International Congress</s1>
<s3>Vancouver CAN</s3>
<s4>1999-07-25</s4>
</fA30>
</pR>
</standard>
<server>
<NO>PASCAL 03-0237962 INIST</NO>
<ET>Apomorphine: A novel effect for an old compound</ET>
<AU>SCARSELLI (Marco); ARMOGIDA (Marianna); PARDINI (Carla); CHIACCHIO (Serena); CORSINI (Giovanni U.); CALNE (Donald); CALNE (Susan M.)</AU>
<AF>Department of Neuroscience, University of Pisa/56126 Pisa/Italie (1 aut., 2 aut., 3 aut., 4 aut., 5 aut.); Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon/Vancouver, British Columbia/Canada (1 aut., 2 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Advances in neurology; ISSN 0091-3952; Coden ADNRA3; Etats-Unis; Da. 2001; Vol. 86; Pp. 367-372; Bibl. 27 ref.</SO>
<LA>Anglais</LA>
<CC>002B17G; 002B02B10</CC>
<FD>Apomorphine; Parkinson maladie; Traitement; Chimiothérapie; Antiparkinsonien; Homme; Agoniste; Récepteur dopaminergique</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Treatment; Chemotherapy; Antiparkinson agent; Human; Agonist; Dopamine receptor</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Parkinson enfermedad; Tratamiento; Quimioterapia; Antiparkinsoniano; Hombre; Agonista; Receptor dopaminérgico</SD>
<LO>INIST-15741.354000109446770380</LO>
<ID>03-0237962</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A92 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000A92 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:03-0237962
   |texte=   Apomorphine: A novel effect for an old compound
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022